{
  "frames":[
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-5-71",
      "text":"NO production; which was blocked by a selective NFkappaB inhibitor",
      "arguments":[
        {
          "text":"NO",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-5-20"
        },
        {
          "text":"NFkappaB inhibitor",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-5-21"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":746,
        "object-type":"relative-pos"
      },
      "trigger":"blocked",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":680,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-5",
      "found-by":"Negative_activation_syntax_6_verb",
      "verbose-text":"LPS caused a time dependent increase in NOS2 mRNA levels and NO production; which was blocked by a selective NFkappaB inhibitor."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-5-70",
      "text":"NOS2 mRNA levels and NO production; which was blocked by a selective NFkappaB inhibitor",
      "arguments":[
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-5-19"
        },
        {
          "text":"NFkappaB inhibitor",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-5-21"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":746,
        "object-type":"relative-pos"
      },
      "trigger":"blocked",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":659,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-5",
      "found-by":"Negative_activation_syntax_6_verb",
      "verbose-text":"LPS caused a time dependent increase in NOS2 mRNA levels and NO production; which was blocked by a selective NFkappaB inhibitor."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-6-41",
      "text":"NE dose-dependently reduced NOS2 expression and NO generation, via activation of beta2-adrenergic receptors (beta2-ARs), and reduced loss of inhibitory IkBalpha protein",
      "arguments":[
        {
          "text":"IkBalpha protein",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-6-27"
        },
        {
          "text":"NE",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-6-22"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":916,
        "object-type":"relative-pos"
      },
      "trigger":"reduced",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":748,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-6",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"NE dose-dependently reduced NOS2 expression and NO generation, via activation of beta2-adrenergic receptors (beta2-ARs), and reduced loss of inhibitory IkBalpha protein."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-6-16",
      "text":"NE dose-dependently reduced NOS2 expression and NO",
      "arguments":[
        {
          "text":"NO",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-6-24"
        },
        {
          "text":"NE",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-6-22"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":798,
        "object-type":"relative-pos"
      },
      "trigger":"reduced",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":748,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-6",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"NE dose-dependently reduced NOS2 expression and NO generation, via activation of beta2-adrenergic receptors (beta2-ARs), and reduced loss of inhibitory IkBalpha protein."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-9-64",
      "text":"NE potently blocked microglial IL-1beta",
      "arguments":[
        {
          "text":"IL-1beta",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-9-35"
        },
        {
          "text":"NE",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-9-34"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":1188,
        "object-type":"relative-pos"
      },
      "trigger":"blocked",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":1149,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-9",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"A role for IL-1beta was suggested since NE potently blocked microglial IL-1beta production."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-12-29",
      "text":"NE reduces microglial NOS2 expression and IL-1beta",
      "arguments":[
        {
          "text":"IL-1beta",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-12-45"
        },
        {
          "text":"NE",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-12-43"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":1532,
        "object-type":"relative-pos"
      },
      "trigger":"reduces",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":1482,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-12",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"NE reduces microglial NOS2 expression and IL-1beta production, however IL-1beta does not play a critical role in NOS2 induction nor in mediating NE suppressive effects."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-12-28",
      "text":"NE reduces microglial NOS2",
      "arguments":[
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-12-44"
        },
        {
          "text":"NE",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-12-43"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":1508,
        "object-type":"relative-pos"
      },
      "trigger":"reduces",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":1482,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-12",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"NE reduces microglial NOS2 expression and IL-1beta production, however IL-1beta does not play a critical role in NOS2 induction nor in mediating NE suppressive effects."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-13-21",
      "text":"cAMP may modulate NOS2",
      "arguments":[
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-13-50"
        },
        {
          "text":"cAMP",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-13-49"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":1709,
        "object-type":"relative-pos"
      },
      "trigger":"modulate",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":1687,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-13",
      "found-by":"Positive_activation_syntax_1_verb",
      "verbose-text":"Changes in magnitude or kinetics of cAMP may modulate NOS2 induction as well as suppression by NE."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-26-68",
      "text":"inhibited by the beta-AR non selective antagonist propanol",
      "arguments":[
        {
          "text":"propanol",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-26-106"
        },
        {
          "text":"beta-AR",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-26-105"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":4430,
        "object-type":"relative-pos"
      },
      "trigger":"inhibited",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":4372,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-26",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"Rat cortical microglia express all different types of ARs [XREF_BIBR], and treatment with NE results in increased levels of cAMP within the cells which can be inhibited by the beta-AR non selective antagonist propanol [XREF_BIBR]."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-28-22",
      "text":"NE reduced NO",
      "arguments":[
        {
          "text":"NO",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-28-109"
        },
        {
          "text":"NE",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-28-108"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":4558,
        "object-type":"relative-pos"
      },
      "trigger":"reduced",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":4545,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-28",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"NE reduced NO production in N9 microglial cells [XREF_BIBR] and in rat microglia [XREF_BIBR], but increased IL-1beta mRNA in rat microglia [XREF_BIBR]."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-29-57",
      "text":"cAMP (analogs such as dibutyryl-cyclic AMP (dbcAMP), activators of adenylate cyclase",
      "arguments":[
        {
          "text":"cAMP",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-29-115"
        },
        {
          "text":"adenylate cyclase",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-29-117"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":4820,
        "object-type":"relative-pos"
      },
      "trigger":"activators",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":4736,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-29",
      "found-by":"Positive_activation_syntax_7_noun",
      "verbose-text":"Other agents which increase microglial cAMP (analogs such as dibutyryl-cyclic AMP (dbcAMP), activators of adenylate cyclase (AC), or PGE2) also modulate inflammatory responses, however in contrast to astrocytes, both up as well as down regulation of NOS2 and IL-1beta has been observed [XREF_BIBR, XREF_BIBR]."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-32-37",
      "text":"NE dose-dependently blocked microglial NOS2",
      "arguments":[
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-32-135"
        },
        {
          "text":"NE",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-32-134"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":5473,
        "object-type":"relative-pos"
      },
      "trigger":"blocked",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":5430,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-32",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"We observed that, as found for astrocytes, NE dose-dependently blocked microglial NOS2 expression, via beta2-ARs activation."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-33-30",
      "text":"NE more potently reduced IL-1beta",
      "arguments":[
        {
          "text":"IL-1beta",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-33-138"
        },
        {
          "text":"NE",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-33-137"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":5564,
        "object-type":"relative-pos"
      },
      "trigger":"reduced",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":5531,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-33",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"In the same cells, NE more potently reduced IL-1beta production, reaching close to 100% attenuation at low concentrations of NE (1 to 10 muM)."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-37-32",
      "text":"LPS induces NOS2",
      "arguments":[
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-37-148"
        },
        {
          "text":"LPS",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-37-147"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":6101,
        "object-type":"relative-pos"
      },
      "trigger":"induces",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":6085,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-37",
      "found-by":"Positive_activation_syntax_1_verb",
      "verbose-text":"LPS induces NOS2 expression in microglia."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-39-67",
      "text":"LPS did not induce significant microglial cell death",
      "arguments":[
        {
          "text":"death",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-39-155"
        },
        {
          "text":"LPS",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-39-153"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":6412,
        "object-type":"relative-pos"
      },
      "trigger":"induce",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":6360,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-39",
      "found-by":"Positive_activation_syntax_1_verb",
      "verbose-text":"This concentration of LPS did not induce significant microglial cell death (assessed by LDH release); nor did higher concentrations of LPS result in significantly higher levels of nitrite production (data not shown)."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-42-17",
      "text":"NE inhibits nitrite accumulation and NO",
      "arguments":[
        {
          "text":"NO",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-42-167"
        },
        {
          "text":"NE",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-42-166"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":7193,
        "object-type":"relative-pos"
      },
      "trigger":"inhibits",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":7154,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-42",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"NE inhibits nitrite accumulation and NO production."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-45-66",
      "text":"NE reduced NOS2",
      "arguments":[
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-45-176"
        },
        {
          "text":"NE",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-45-175"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":7589,
        "object-type":"relative-pos"
      },
      "trigger":"reduced",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":7574,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-45",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"Measurements of NO using H 2 DCF-DA showed that NE reduced NOS2 derived NO after 4 hr of incubation, although at this time point significant inhibition was observed only at the higher (10 muM) NE concentration used."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-52-8",
      "text":"KT-5720                   or compound H89 which inhibits both PKA and PKC",
      "arguments":[
        {
          "text":"PKC",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-52-208"
        },
        {
          "text":"KT-5720",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-52-205"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":9037,
        "object-type":"relative-pos"
      },
      "trigger":"inhibits",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":8964,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-52",
      "found-by":"Negative_activation_syntax_5_verb",
      "verbose-text":"However, co-incubation with the selective PKA inhibitor KT-5720 or compound H89 which inhibits both PKA and PKC did not reverse NE effects, suggesting that PKA activation does not play a major role in reducing NOS2 activity (or expression)."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-52-5",
      "text":"PKA inhibitor KT-5720                   or compound H89 which inhibits both PKA",
      "arguments":[
        {
          "text":"PKA",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-52-207"
        },
        {
          "text":"PKA inhibitor",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-52-204"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":9029,
        "object-type":"relative-pos"
      },
      "trigger":"inhibits",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":8950,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-52",
      "found-by":"Negative_activation_syntax_5_verb",
      "verbose-text":"However, co-incubation with the selective PKA inhibitor KT-5720 or compound H89 which inhibits both PKA and PKC did not reverse NE effects, suggesting that PKA activation does not play a major role in reducing NOS2 activity (or expression)."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-52-6",
      "text":"PKA inhibitor KT-5720                   or compound H89 which inhibits both PKA and PKC",
      "arguments":[
        {
          "text":"PKC",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-52-208"
        },
        {
          "text":"PKA inhibitor",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-52-204"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":9037,
        "object-type":"relative-pos"
      },
      "trigger":"inhibits",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":8950,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-52",
      "found-by":"Negative_activation_syntax_5_verb",
      "verbose-text":"However, co-incubation with the selective PKA inhibitor KT-5720 or compound H89 which inhibits both PKA and PKC did not reverse NE effects, suggesting that PKA activation does not play a major role in reducing NOS2 activity (or expression)."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-52-7",
      "text":"KT-5720                   or compound H89 which inhibits both PKA",
      "arguments":[
        {
          "text":"PKA",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-52-207"
        },
        {
          "text":"KT-5720",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-52-205"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":9029,
        "object-type":"relative-pos"
      },
      "trigger":"inhibits",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":8964,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-52",
      "found-by":"Negative_activation_syntax_5_verb",
      "verbose-text":"However, co-incubation with the selective PKA inhibitor KT-5720 or compound H89 which inhibits both PKA and PKC did not reverse NE effects, suggesting that PKA activation does not play a major role in reducing NOS2 activity (or expression)."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-55-56",
      "text":"LPS induced nitrite production                   and NOS2",
      "arguments":[
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-55-225"
        },
        {
          "text":"LPS",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-55-224"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":9673,
        "object-type":"relative-pos"
      },
      "trigger":"induced",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":9616,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-55",
      "found-by":"Positive_activation_syntax_1_verb",
      "verbose-text":"Unexpectedly, in these cells inhibition of AC activity reduced LPS induced nitrite production and NOS2 expression, and SQ 22536 further potentiated NE inhibitory effects."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-55-11",
      "text":"AC activity reduced LPS induced nitrite production                   and NOS2",
      "arguments":[
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-55-225"
        },
        {
          "text":"AC",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-55-223"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":9673,
        "object-type":"relative-pos"
      },
      "trigger":"reduced",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":9596,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-55",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"Unexpectedly, in these cells inhibition of AC activity reduced LPS induced nitrite production and NOS2 expression, and SQ 22536 further potentiated NE inhibitory effects."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-56-31",
      "text":"NE reduces NOS2",
      "arguments":[
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-56-229"
        },
        {
          "text":"NE",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-56-228"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":9796,
        "object-type":"relative-pos"
      },
      "trigger":"reduces",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":9781,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-56",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"NE reduces NOS2 mRNA and increases IkBalpha levels."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-56-69",
      "text":"NE reduces NOS2 mRNA and increases IkBalpha",
      "arguments":[
        {
          "text":"IkBalpha",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-56-230"
        },
        {
          "text":"NE",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-56-228"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":9824,
        "object-type":"relative-pos"
      },
      "trigger":"increases",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":9781,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-56",
      "found-by":"Positive_activation_syntax_1_verb",
      "verbose-text":"NE reduces NOS2 mRNA and increases IkBalpha levels."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-57-40",
      "text":"LPS increased NOS2",
      "arguments":[
        {
          "text":"LPS",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-57-231"
        },
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-57-232"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":9911,
        "object-type":"relative-pos"
      },
      "trigger":"increased",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":9893,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-57",
      "found-by":"Positive_activation_token_1_verb",
      "verbose-text":"Quantitative RT-PCR analysis showed that LPS increased NOS2 mRNA steady state levels approximately 15-fold versus control values after 4 hr of incubation, and further increased levels (to roughly 50-fold control levels) at 24 hr incubation."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-58-49",
      "text":"NE reduced the increase in NOS2",
      "arguments":[
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-58-234"
        },
        {
          "text":"NE",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-58-233"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":10140,
        "object-type":"relative-pos"
      },
      "trigger":"reduced",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":10109,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-58",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"The presence of NE reduced the increase in NOS2 mRNA levels at both 4 and 24 hr, suggesting an effect of NE at the transcriptional and or post-transcriptional level."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-59-20",
      "text":"suppression of NOS2 by NE",
      "arguments":[
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-59-237"
        },
        {
          "text":"NE",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-59-238"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":10304,
        "object-type":"relative-pos"
      },
      "trigger":"suppression",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":10279,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-59",
      "found-by":"Negative_activation_token_2_noun",
      "verbose-text":"In astrocytes, the suppression of NOS2 by NE involves modulation of the NFkappaB : IkappaB signaling system [XREF_BIBR]."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-64-39",
      "text":"NE may increase IkappaBalpha",
      "arguments":[
        {
          "text":"IkappaBalpha",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-64-260"
        },
        {
          "text":"NE",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-64-259"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":11160,
        "object-type":"relative-pos"
      },
      "trigger":"increase",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":11132,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-64",
      "found-by":"Positive_activation_syntax_1_verb",
      "verbose-text":"This suggests that, similar to what is observed in astrocytes [XREF_BIBR], NE may increase IkappaBalpha re-synthesis."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-65-50",
      "text":"NE reduces IL-1beta",
      "arguments":[
        {
          "text":"IL-1beta",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-65-262"
        },
        {
          "text":"NE",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-65-261"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":11197,
        "object-type":"relative-pos"
      },
      "trigger":"reduces",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":11178,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-65",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"NE reduces IL-1beta release."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-66-54",
      "text":"LPS increased microglia IL-1beta",
      "arguments":[
        {
          "text":"IL-1beta",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-66-266"
        },
        {
          "text":"LPS",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-66-264"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":11296,
        "object-type":"relative-pos"
      },
      "trigger":"increased",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":11264,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-66",
      "found-by":"Positive_activation_syntax_1_verb",
      "verbose-text":"As previously reported [XREF_BIBR, XREF_BIBR, XREF_BIBR], LPS increased microglia IL-1beta production."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-74-44",
      "text":"induction of NOS2 by LPS",
      "arguments":[
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-74-284"
        },
        {
          "text":"LPS",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-74-285"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":12462,
        "object-type":"relative-pos"
      },
      "trigger":"induction",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":12438,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-74",
      "found-by":"Positive_activation_token_2_noun",
      "verbose-text":"To further test an involvement of IL-1beta in the induction of NOS2 by LPS, we used microglial cells derived from caspase-1 deficient mice which can not produce the mature form of IL-1beta."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-80-48",
      "text":"NE concentrations which are needed to activate beta2-ARs [",
      "arguments":[
        {
          "text":"beta2-ARs [",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-80-311"
        },
        {
          "text":"NE",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-80-310"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":13639,
        "object-type":"relative-pos"
      },
      "trigger":"activate",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":13581,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-80",
      "found-by":"Positive_activation_syntax_5_verb",
      "verbose-text":"Although NE has a high affinity for, and at low doses (100 nM to 1 muM) can increase cAMP via microglial beta1 and beta3 ARs, even greater increases in cAMP were found at higher (1-10 muM) NE concentrations which are needed to activate beta2-ARs [XREF_BIBR]."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-81-55",
      "text":"NE needed to reduce NOS2",
      "arguments":[
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-81-313"
        },
        {
          "text":"NE",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-81-312"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":13696,
        "object-type":"relative-pos"
      },
      "trigger":"reduce",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":13672,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-81",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"Thus, the amounts of NE needed to reduce NOS2 expression may reflect a requirement to activate beta2-ARs in our studies, although other non receptor mediated effects can not be ruled out."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-82-51",
      "text":"isoproterenol decreased NO",
      "arguments":[
        {
          "text":"NO",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-82-317"
        },
        {
          "text":"isoproterenol",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-82-316"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":13938,
        "object-type":"relative-pos"
      },
      "trigger":"decreased",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":13912,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-82",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"Previous studies of adrenergic regulation of microglial NOS2 are limited : isoproterenol decreased NO release [XREF_BIBR]; and in one study [XREF_BIBR], NE, terbutaline (a beta2-AR agonist), dobutamine (a beta1-AR agonist) as well as phenylephrine (an alpha1-AR agonist) all reduced NO production despite different effects on cAMP elevation; suggesting that adrenergic stimulation can attenuate NOS2 irrespective of effects on cAMP."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-82-34",
      "text":"dobutamine (a beta1-AR agonist) as well as phenylephrine (an alpha1-AR agonist) all reduced NO",
      "arguments":[
        {
          "text":"NO",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-82-324"
        },
        {
          "text":"dobutamine",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-82-321"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":14122,
        "object-type":"relative-pos"
      },
      "trigger":"reduced",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":14028,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-82",
      "found-by":"Negative_activation_syntax_5_verb",
      "verbose-text":"Previous studies of adrenergic regulation of microglial NOS2 are limited : isoproterenol decreased NO release [XREF_BIBR]; and in one study [XREF_BIBR], NE, terbutaline (a beta2-AR agonist), dobutamine (a beta1-AR agonist) as well as phenylephrine (an alpha1-AR agonist) all reduced NO production despite different effects on cAMP elevation; suggesting that adrenergic stimulation can attenuate NOS2 irrespective of effects on cAMP."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-82-35",
      "text":"phenylephrine (an alpha1-AR agonist) all reduced NO",
      "arguments":[
        {
          "text":"NO",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-82-324"
        },
        {
          "text":"phenylephrine",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-82-323"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":14122,
        "object-type":"relative-pos"
      },
      "trigger":"reduced",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":14071,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-82",
      "found-by":"Negative_activation_syntax_5_verb",
      "verbose-text":"Previous studies of adrenergic regulation of microglial NOS2 are limited : isoproterenol decreased NO release [XREF_BIBR]; and in one study [XREF_BIBR], NE, terbutaline (a beta2-AR agonist), dobutamine (a beta1-AR agonist) as well as phenylephrine (an alpha1-AR agonist) all reduced NO production despite different effects on cAMP elevation; suggesting that adrenergic stimulation can attenuate NOS2 irrespective of effects on cAMP."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-82-33",
      "text":"terbutaline (a beta2-AR agonist), dobutamine (a beta1-AR agonist) as well as phenylephrine (an alpha1-AR agonist) all reduced NO",
      "arguments":[
        {
          "text":"NO",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-82-324"
        },
        {
          "text":"terbutaline",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-82-319"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":14122,
        "object-type":"relative-pos"
      },
      "trigger":"reduced",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":13994,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-82",
      "found-by":"Negative_activation_syntax_5_verb",
      "verbose-text":"Previous studies of adrenergic regulation of microglial NOS2 are limited : isoproterenol decreased NO release [XREF_BIBR]; and in one study [XREF_BIBR], NE, terbutaline (a beta2-AR agonist), dobutamine (a beta1-AR agonist) as well as phenylephrine (an alpha1-AR agonist) all reduced NO production despite different effects on cAMP elevation; suggesting that adrenergic stimulation can attenuate NOS2 irrespective of effects on cAMP."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-83-53",
      "text":"cAMP modulate microglial NOS2",
      "arguments":[
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-83-329"
        },
        {
          "text":"cAMP",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-83-328"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":14385,
        "object-type":"relative-pos"
      },
      "trigger":"modulate",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":14356,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-83",
      "found-by":"Positive_activation_syntax_1_verb",
      "verbose-text":"Our results are consistent with several reports showing that intracellular levels of cAMP modulate microglial NOS2 expression."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-84-65",
      "text":"NOS2 expression was reduced by cAMP",
      "arguments":[
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-84-330"
        },
        {
          "text":"cAMP",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-84-331"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":14433,
        "object-type":"relative-pos"
      },
      "trigger":"reduced",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":14398,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-84",
      "found-by":"Negative_activation_syntax_2_verb",
      "verbose-text":"NOS2 expression was reduced by cAMP analogs in microglia [XREF_BIBR]; by PGE2 (as well as FSK and dbcAMP) in enriched microglia [XREF_BIBR, XREF_BIBR]; and in mixed neuron : microglial co-cultures [XREF_BIBR]."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-86-10",
      "text":"NOS2 is not always suppressed by elevated cAMP",
      "arguments":[
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-86-343"
        },
        {
          "text":"cAMP",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-86-344"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":14939,
        "object-type":"relative-pos"
      },
      "trigger":"suppressed",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":14893,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-86",
      "found-by":"Negative_activation_syntax_2_verb",
      "verbose-text":"However, NOS2 is not always suppressed by elevated cAMP, and there are several studies showing that in contrast to being inhibitory, cAMP potentiates NOS2 expression [XREF_BIBR]."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-86-62",
      "text":"cAMP potentiates NOS2",
      "arguments":[
        {
          "text":"cAMP",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-86-345"
        },
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-86-346"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":15038,
        "object-type":"relative-pos"
      },
      "trigger":"potentiates",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":15017,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-86",
      "found-by":"Positive_activation_token_1_verb",
      "verbose-text":"However, NOS2 is not always suppressed by elevated cAMP, and there are several studies showing that in contrast to being inhibitory, cAMP potentiates NOS2 expression [XREF_BIBR]."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-93-47",
      "text":"PKA inhibitors did not reverse the inhibitory effects of NE",
      "arguments":[
        {
          "text":"NE",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-93-378"
        },
        {
          "text":"PKA inhibitors",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-93-377"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":16621,
        "object-type":"relative-pos"
      },
      "trigger":"reverse",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":16562,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-93",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"Although PKA is a primary target for activation by cAMP, we found that selective PKA inhibitors did not reverse the inhibitory effects of NE, suggesting that other cAMP dependent signaling pathways, such as the newly characterized EPAC and RAP system [XREF_BIBR] may mediate NE inhibitory actions in microglia."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-94-76",
      "text":"PKA activation in NOS2",
      "arguments":[
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-94-387"
        },
        {
          "text":"PKA",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-94-386"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":16996,
        "object-type":"relative-pos"
      },
      "trigger":"activation",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":16974,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-94",
      "found-by":"Positive_activation_syntax_3_noun",
      "verbose-text":"However interpretation of results with PKA inhibitors are complicated by the fact that these inhibitors blocked LPS dependent nitrite production, suggesting a role for PKA activation in NOS2 induction."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-95-42",
      "text":"AC inhibitor SQ22536 did not reverse NE",
      "arguments":[
        {
          "text":"NE",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-95-390"
        },
        {
          "text":"AC inhibitor",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-95-388"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":17085,
        "object-type":"relative-pos"
      },
      "trigger":"reverse",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":17046,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-95",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"Similarly, our results show that the AC inhibitor SQ22536 did not reverse NE actions, and by itself reduced LPS induced NOS2 activity and expression."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-95-43",
      "text":"SQ22536 did not reverse NE",
      "arguments":[
        {
          "text":"NE",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-95-390"
        },
        {
          "text":"SQ22536",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-95-389"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":17085,
        "object-type":"relative-pos"
      },
      "trigger":"reverse",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":17059,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-95",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"Similarly, our results show that the AC inhibitor SQ22536 did not reverse NE actions, and by itself reduced LPS induced NOS2 activity and expression."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-95-72",
      "text":"LPS-induced NOS2",
      "arguments":[
        {
          "text":"LPS",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-95-391"
        },
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-95-392"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":17133,
        "object-type":"relative-pos"
      },
      "trigger":"induced",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":17117,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-95",
      "found-by":"Positive_early_activation",
      "verbose-text":"Similarly, our results show that the AC inhibitor SQ22536 did not reverse NE actions, and by itself reduced LPS induced NOS2 activity and expression."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-96-36",
      "text":"reverse NOS2 suppression due to activation of the prostaglandin EP2 receptors by PGE2",
      "arguments":[
        {
          "text":"EP2 receptors",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-96-397"
        },
        {
          "text":"PGE2",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-96-398"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":17401,
        "object-type":"relative-pos"
      },
      "trigger":"reverse",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":17316,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-96",
      "found-by":"Negative_activation_syntax_3_verb",
      "verbose-text":"This finding is in contrast with previous studies showing no effects of this agent (or other AC inhibitors) on NOS2 induction, yet able to reverse NOS2 suppression due to activation of the prostaglandin EP2 receptors by PGE2 [XREF_BIBR]."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-97-24",
      "text":"AC activator forskolin",
      "arguments":[
        {
          "text":"AC",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-97-406"
        },
        {
          "text":"forskolin",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-97-407"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":17773,
        "object-type":"relative-pos"
      },
      "trigger":"activator",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":17751,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-97",
      "found-by":"Positive_activation_token_1_noun",
      "verbose-text":"However, in the same study contradictory effects of AC activation on NOS2 were observed, since sulprostone, a potent agonist for the EP1 and EP3 receptors which inhibits AC activity, inhibited LPS induced nitrite production; furthermore nitrite production was also increased at the higher concentrations of isoproterenol (> 100 nM), the AC activator forskolin (FSK,> 100 muM) and dbcAMP (> 10 muM)."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-97-23",
      "text":"AC activator forskolin",
      "arguments":[
        {
          "text":"AC",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-97-406"
        },
        {
          "text":"forskolin",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-97-407"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":17773,
        "object-type":"relative-pos"
      },
      "trigger":"activator",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":17751,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-97",
      "found-by":"Positive_activation_token_1_verb",
      "verbose-text":"However, in the same study contradictory effects of AC activation on NOS2 were observed, since sulprostone, a potent agonist for the EP1 and EP3 receptors which inhibits AC activity, inhibited LPS induced nitrite production; furthermore nitrite production was also increased at the higher concentrations of isoproterenol (> 100 nM), the AC activator forskolin (FSK,> 100 muM) and dbcAMP (> 10 muM)."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-98-52",
      "text":"forskolin (10 to 50 muM) increased NO",
      "arguments":[
        {
          "text":"NO",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-98-413"
        },
        {
          "text":"forskolin",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-98-412"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":17962,
        "object-type":"relative-pos"
      },
      "trigger":"increased",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":17925,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-98",
      "found-by":"Positive_activation_syntax_1_verb",
      "verbose-text":"AC activators also had contrasting effects on Abeta induced nitrite production in microglia, where low doses of forskolin (10 to 50 muM) increased NO release, and a higher dose (100 muM) reduced NO release [XREF_BIBR]."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-101-74",
      "text":"dopamine metabolite NAMDA which increases cAMP",
      "arguments":[
        {
          "text":"cAMP",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-101-431"
        },
        {
          "text":"dopamine",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-101-430"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":18685,
        "object-type":"relative-pos"
      },
      "trigger":"increases",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":18639,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-101",
      "found-by":"Positive_activation_syntax_5_verb",
      "verbose-text":"Thus, Si et al. [XREF_BIBR] showed that the PDE inhibitor propentofylline reduced LPS induced TNFalpha and IL-1beta release; Caggiano and Kraig [XREF_BIBR, XREF_BIBR] showed that PGE2 acting via EP2 receptors (and increased cAMP) reduced IL-1beta production; and Cho et al. [XREF_BIBR] showed that the dopamine metabolite NAMDA which increases cAMP and CREB activation reduced IL-1beta mRNA levels."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-101-4",
      "text":"LPS induced TNFalpha",
      "arguments":[
        {
          "text":"LPS",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-101-3"
        },
        {
          "text":"TNFalpha",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-101-4"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":18440,
        "object-type":"relative-pos"
      },
      "trigger":"induced",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":18420,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-101",
      "found-by":"Positive_early_activation",
      "verbose-text":"Thus, Si et al. [XREF_BIBR] showed that the PDE inhibitor propentofylline reduced LPS induced TNFalpha and IL-1beta release; Caggiano and Kraig [XREF_BIBR, XREF_BIBR] showed that PGE2 acting via EP2 receptors (and increased cAMP) reduced IL-1beta production; and Cho et al. [XREF_BIBR] showed that the dopamine metabolite NAMDA which increases cAMP and CREB activation reduced IL-1beta mRNA levels."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-101-75",
      "text":"dopamine metabolite NAMDA which increases cAMP and CREB",
      "arguments":[
        {
          "text":"CREB",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-101-432"
        },
        {
          "text":"dopamine",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-101-430"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":18694,
        "object-type":"relative-pos"
      },
      "trigger":"increases",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":18639,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-101",
      "found-by":"Positive_activation_syntax_5_verb",
      "verbose-text":"Thus, Si et al. [XREF_BIBR] showed that the PDE inhibitor propentofylline reduced LPS induced TNFalpha and IL-1beta release; Caggiano and Kraig [XREF_BIBR, XREF_BIBR] showed that PGE2 acting via EP2 receptors (and increased cAMP) reduced IL-1beta production; and Cho et al. [XREF_BIBR] showed that the dopamine metabolite NAMDA which increases cAMP and CREB activation reduced IL-1beta mRNA levels."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-101-3",
      "text":"PDE inhibitor propentofylline reduced LPS induced TNFalpha",
      "arguments":[
        {
          "text":"LPS induced TNFalpha",
          "argument-type":"event",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"evem-PMC500870-UAZ-r1-500870-101-4"
        },
        {
          "text":"PDE inhibitor",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-101-5"
        }
      ],
      "type":"regulation",
      "frame-type":"event-mention",
      "subtype":"negative-regulation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":18440,
        "object-type":"relative-pos"
      },
      "trigger":"reduced",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":18382,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-101",
      "found-by":"Negative_regulation_syntax_1_verb",
      "verbose-text":"Thus, Si et al. [XREF_BIBR] showed that the PDE inhibitor propentofylline reduced LPS induced TNFalpha and IL-1beta release; Caggiano and Kraig [XREF_BIBR, XREF_BIBR] showed that PGE2 acting via EP2 receptors (and increased cAMP) reduced IL-1beta production; and Cho et al. [XREF_BIBR] showed that the dopamine metabolite NAMDA which increases cAMP and CREB activation reduced IL-1beta mRNA levels."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-102-15",
      "text":"isoproterenol reduced LPS induced IL-1beta as well as TNFalpha",
      "arguments":[
        {
          "text":"TNFalpha",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-102-438"
        },
        {
          "text":"isoproterenol",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-102-435"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":18861,
        "object-type":"relative-pos"
      },
      "trigger":"reduced",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":18799,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-102",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"In contrast, Hetier [XREF_BIBR] found that the beta-AR agonist isoproterenol reduced LPS induced IL-1beta as well as TNFalpha production, however while TNFalpha mRNA was reduced, IL-1beta mRNA was increased."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-102-12",
      "text":"beta-AR agonist isoproterenol reduced LPS induced IL-1beta",
      "arguments":[
        {
          "text":"IL-1beta",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-102-437"
        },
        {
          "text":"beta-AR",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-102-434"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":18841,
        "object-type":"relative-pos"
      },
      "trigger":"reduced",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":18783,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-102",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"In contrast, Hetier [XREF_BIBR] found that the beta-AR agonist isoproterenol reduced LPS induced IL-1beta as well as TNFalpha production, however while TNFalpha mRNA was reduced, IL-1beta mRNA was increased."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-102-14",
      "text":"isoproterenol reduced LPS induced IL-1beta",
      "arguments":[
        {
          "text":"IL-1beta",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-102-437"
        },
        {
          "text":"isoproterenol",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-102-435"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":18841,
        "object-type":"relative-pos"
      },
      "trigger":"reduced",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":18799,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-102",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"In contrast, Hetier [XREF_BIBR] found that the beta-AR agonist isoproterenol reduced LPS induced IL-1beta as well as TNFalpha production, however while TNFalpha mRNA was reduced, IL-1beta mRNA was increased."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-102-13",
      "text":"beta-AR agonist isoproterenol reduced LPS induced IL-1beta as well as TNFalpha",
      "arguments":[
        {
          "text":"TNFalpha",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-102-438"
        },
        {
          "text":"beta-AR",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-102-434"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":18861,
        "object-type":"relative-pos"
      },
      "trigger":"reduced",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":18783,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-102",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"In contrast, Hetier [XREF_BIBR] found that the beta-AR agonist isoproterenol reduced LPS induced IL-1beta as well as TNFalpha production, however while TNFalpha mRNA was reduced, IL-1beta mRNA was increased."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-103-9",
      "text":"isoproterenol (and dbcAMP) increased IL-1beta mRNA",
      "arguments":[
        {
          "text":"IL-1beta mRNA",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-103-442"
        },
        {
          "text":"isoproterenol",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-103-441"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":19043,
        "object-type":"relative-pos"
      },
      "trigger":"increased",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":18993,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-103",
      "found-by":"Positive_activation_syntax_1_verb",
      "verbose-text":"Tomozawa et al. [XREF_BIBR] similarly found that isoproterenol (and dbcAMP) increased IL-1beta mRNA in microglial (although not in astrocytes); and Petrova et al. [XREF_BIBR] reported that PGE2 also reduced IL-1beta secretion, but increased IL-1beta mRNA levels."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-103-61",
      "text":"PGE2 also reduced IL-1beta secretion, but increased IL-1beta mRNA",
      "arguments":[
        {
          "text":"IL-1beta mRNA",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-103-446"
        },
        {
          "text":"PGE2",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-103-444"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":19198,
        "object-type":"relative-pos"
      },
      "trigger":"increased",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":19133,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-103",
      "found-by":"Positive_activation_syntax_1_verb",
      "verbose-text":"Tomozawa et al. [XREF_BIBR] similarly found that isoproterenol (and dbcAMP) increased IL-1beta mRNA in microglial (although not in astrocytes); and Petrova et al. [XREF_BIBR] reported that PGE2 also reduced IL-1beta secretion, but increased IL-1beta mRNA levels."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-103-60",
      "text":"PGE2 also reduced IL-1beta",
      "arguments":[
        {
          "text":"IL-1beta",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-103-445"
        },
        {
          "text":"PGE2",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-103-444"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":19159,
        "object-type":"relative-pos"
      },
      "trigger":"reduced",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":19133,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-103",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"Tomozawa et al. [XREF_BIBR] similarly found that isoproterenol (and dbcAMP) increased IL-1beta mRNA in microglial (although not in astrocytes); and Petrova et al. [XREF_BIBR] reported that PGE2 also reduced IL-1beta secretion, but increased IL-1beta mRNA levels."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-106-18",
      "text":"NE to reduce NOS2",
      "arguments":[
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-106-458"
        },
        {
          "text":"NE",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-106-457"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":19780,
        "object-type":"relative-pos"
      },
      "trigger":"reduce",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":19763,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-106",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"The suppression by NE of IL-1beta production was similar to that seen for NOS2, which suggested that the ability of NE to reduce NOS2 may be related to its ability to reduce IL-1beta."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-113-38",
      "text":"LPS activated microglia with malonic acid C60 derivatives reduced NOS2",
      "arguments":[
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-113-488"
        },
        {
          "text":"LPS",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-113-484"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":20997,
        "object-type":"relative-pos"
      },
      "trigger":"activated",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":20927,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-113",
      "found-by":"Positive_activation_syntax_1_verb",
      "verbose-text":"More recently, treatment of LPS activated microglia with malonic acid C60 derivatives reduced NOS2 mRNA expression, although these same reagents increased the release of IL-1beta [XREF_BIBR]."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-116-46",
      "text":"IL-1beta in combination with other cytokines (IFNgamma and/or TNFalpha) can induce rodent NOS2",
      "arguments":[
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-116-499"
        },
        {
          "text":"IL-1beta",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-116-496"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":21482,
        "object-type":"relative-pos"
      },
      "trigger":"induce",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":21388,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-116",
      "found-by":"Positive_activation_syntax_1_verb",
      "verbose-text":"In astrocytes, IL-1beta in combination with other cytokines (IFNgamma and/or TNFalpha) can induce rodent NOS2 [XREF_BIBR, XREF_BIBR], and a few reports suggest that IL-1beta alone may induce rodent astrocyte NOS2 [XREF_BIBR]."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-116-27",
      "text":"IL-1beta alone may induce rodent astrocyte NOS2",
      "arguments":[
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-116-502"
        },
        {
          "text":"IL-1beta",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-116-500"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":21584,
        "object-type":"relative-pos"
      },
      "trigger":"induce",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":21537,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-116",
      "found-by":"Positive_activation_syntax_1_verb",
      "verbose-text":"In astrocytes, IL-1beta in combination with other cytokines (IFNgamma and/or TNFalpha) can induce rodent NOS2 [XREF_BIBR, XREF_BIBR], and a few reports suggest that IL-1beta alone may induce rodent astrocyte NOS2 [XREF_BIBR]."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-117-73",
      "text":"IL-1beta alone can induce NOS2",
      "arguments":[
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-117-506"
        },
        {
          "text":"IL-1beta",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-117-505"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":21678,
        "object-type":"relative-pos"
      },
      "trigger":"induce",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":21648,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-117",
      "found-by":"Positive_activation_syntax_1_verb",
      "verbose-text":"In contrast, in human fetal and adult astrocytes, IL-1beta alone can induce NOS2 [XREF_BIBR, XREF_BIBR] which is greatly increased by other cytokines [XREF_BIBR]."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-119-19",
      "text":"IL-1beta alone will induce microglial NOS2",
      "arguments":[
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-119-516"
        },
        {
          "text":"IL-1beta",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-119-515"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":22171,
        "object-type":"relative-pos"
      },
      "trigger":"induce",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":22129,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-119",
      "found-by":"Positive_activation_syntax_1_verb",
      "verbose-text":"In contrast to astrocytes, there are no clear reports to indicate that IL-1beta alone will induce microglial NOS2, and in fact human microglial appear more refractory to NOS2 inducers than do rodent cells [XREF_BIBR]."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-120-45",
      "text":"LPS induced IL-1beta",
      "arguments":[
        {
          "text":"LPS",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-120-519"
        },
        {
          "text":"IL-1beta",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-120-520"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":22352,
        "object-type":"relative-pos"
      },
      "trigger":"induced",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":22332,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-120",
      "found-by":"Positive_early_activation",
      "verbose-text":"Our results are consistent with the conclusion that the LPS induced IL-1beta does not play an important role in mediating microglial NOS2 expression."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-121-59",
      "text":"NE reduces microglial NOS2 expression and IL-1beta",
      "arguments":[
        {
          "text":"IL-1beta",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-121-524"
        },
        {
          "text":"NE",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-121-522"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":22513,
        "object-type":"relative-pos"
      },
      "trigger":"reduces",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":22463,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-121",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"The molecular mechanism (s) by which NE reduces microglial NOS2 expression and IL-1beta production and expression are not yet known."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-121-58",
      "text":"NE reduces microglial NOS2",
      "arguments":[
        {
          "text":"NOS2",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-121-523"
        },
        {
          "text":"NE",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-121-522"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":22489,
        "object-type":"relative-pos"
      },
      "trigger":"reduces",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":22463,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-121",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"The molecular mechanism (s) by which NE reduces microglial NOS2 expression and IL-1beta production and expression are not yet known."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-122-2",
      "text":"phosphorylation of inhibitory IkappaB proteins",
      "arguments":[
        {
          "text":"IkappaB proteins",
          "argument-type":"entity",
          "type":"theme",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-122-1"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":22714,
        "object-type":"relative-pos"
      },
      "trigger":"phosphorylation",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":22668,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-122",
      "found-by":"Phosphorylation_syntax_1a_noun",
      "verbose-text":"Work from several laboratories has shown in glial cells that LPS rapidly activates PK cascades which lead to phosphorylation of inhibitory IkappaB proteins, their degradation by the 26S proteasome, and subsequent activation of NFkappaB [XREF_BIBR], necessary for the expression of pro inflammatory genes [XREF_BIBR]."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-122-1",
      "text":"PK cascades which lead to phosphorylation of inhibitory IkappaB proteins",
      "arguments":[
        {
          "text":"phosphorylation of inhibitory IkappaB proteins",
          "argument-type":"event",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"evem-PMC500870-UAZ-r1-500870-122-2"
        },
        {
          "text":"PK",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-122-2"
        }
      ],
      "type":"regulation",
      "frame-type":"event-mention",
      "subtype":"positive-regulation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":22714,
        "object-type":"relative-pos"
      },
      "trigger":"lead",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":22642,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-122",
      "found-by":"Positive_regulation_syntax_7_verb",
      "verbose-text":"Work from several laboratories has shown in glial cells that LPS rapidly activates PK cascades which lead to phosphorylation of inhibitory IkappaB proteins, their degradation by the 26S proteasome, and subsequent activation of NFkappaB [XREF_BIBR], necessary for the expression of pro inflammatory genes [XREF_BIBR]."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-123-63",
      "text":"LPS induced rapid loss of the microglial IkappaBalpha",
      "arguments":[
        {
          "text":"IkappaBalpha",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-123-531"
        },
        {
          "text":"LPS",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-123-530"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":22946,
        "object-type":"relative-pos"
      },
      "trigger":"induced",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":22893,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-123",
      "found-by":"Positive_activation_syntax_1_verb",
      "verbose-text":"We observed that LPS induced rapid loss of the microglial IkappaBalpha protein, while co-incubation with NE reduced that loss and moreover increased IkappaBalpha levels after longer times."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-124-25",
      "text":"NE directly increases transcription",
      "arguments":[
        {
          "text":"transcription",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-124-537"
        },
        {
          "text":"NE",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-124-536"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":23248,
        "object-type":"relative-pos"
      },
      "trigger":"increases",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":23213,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-124",
      "found-by":"Positive_activation_syntax_1_verb",
      "verbose-text":"Several reports suggest that increases in cAMP are associated with increased levels of IkappaBalpha [XREF_BIBR-XREF_BIBR], and we demonstrated that NE directly increases transcription of the IkappaBalpha gene in astrocytes and reduces the overall magnitude of IkBa degradation [XREF_BIBR]."
    },
    {
      "frame-id":"evem-PMC500870-UAZ-r1-500870-124-26",
      "text":"NE directly increases transcription of the IkappaBalpha",
      "arguments":[
        {
          "text":"IkappaBalpha",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-124-538"
        },
        {
          "text":"NE",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC500870-UAZ-r1-500870-124-536"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":23268,
        "object-type":"relative-pos"
      },
      "trigger":"increases",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC500870-UAZ-r1-500870",
        "offset":23213,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC500870-UAZ-r1-500870-124",
      "found-by":"Positive_activation_syntax_1_verb",
      "verbose-text":"Several reports suggest that increases in cAMP are associated with increased levels of IkappaBalpha [XREF_BIBR-XREF_BIBR], and we demonstrated that NE directly increases transcription of the IkappaBalpha gene in astrocytes and reduces the overall magnitude of IkBa degradation [XREF_BIBR]."
    }
  ],
  "object-type":"frame-collection",
  "object-meta":{
    "processing-end":"2016-09-11T16:09:31Z",
    "doc-id":"PMC500870",
    "component-type":"machine",
    "component":"Reach",
    "processing-start":"2016-09-11T16:06:56Z",
    "object-type":"meta-info",
    "organization":"UAZ"
  }
}
